Ovarian Cancer Trial, Recruiting (NCT04997096)

Ovarian Cancer Trial, Recruiting NCT04997096 Sponsor: Dana-Farber Cancer Institute Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04997096 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been recently diagnosed with stage III or IV ovarian or endometrial cancer
You are receiving your first round of chemotherapy (carboplatin and paclitaxel) after surgery
You are 18 years of age or older
Your doctor has confirmed it is safe for you to do moderate to vigorous exercise
You are able to read, write, and understand English
You are willing and able to sign a consent form after having the study explained to you
You are willing to have two blood samples taken as part of the study

Who may not be able to join:

You have existing bone, muscle, nerve, or heart and lung conditions, as decided by your cancer doctor
You have another illness that is not well controlled, as decided by your cancer doctor
You have a mental health condition or personal circumstances that your cancer doctor believes would make it difficult for you to follow the study requirements
You have previously received chemotherapy for cancer treatment (for example, taxane-based chemotherapy for breast cancer)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christina Dieli-Conwright, PhD, Dana-Farber Cancer Institute

Phone: (617) 582-8321

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04997096

Sponsor: Dana-Farber Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: (617) 582-8321

More information: https://clinicaltrials.gov/study/NCT04997096

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been recently diagnosed with stage III or IV ovarian or endometrial cancer
You are receiving your first round of chemotherapy (carboplatin and paclitaxel) after surgery
You are 18 years of age or older
Your doctor has confirmed it is safe for you to do moderate to vigorous exercise
You are able to read, write, and understand English
You are willing and able to sign a consent form after having the study explained to you
You are willing to have two blood samples taken as part of the study

Who may not be able to join:

You have existing bone, muscle, nerve, or heart and lung conditions, as decided by your cancer doctor
You have another illness that is not well controlled, as decided by your cancer doctor
You have a mental health condition or personal circumstances that your cancer doctor believes would make it difficult for you to follow the study requirements
You have previously received chemotherapy for cancer treatment (for example, taxane-based chemotherapy for breast cancer)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dana-Farber Cancer Institute

Registry

ClinicalTrials.gov

Start date

2 April 2022

Est. completion

1 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of patients completing the exercise intervention sessions.; Enrollment Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov